Join a CureDuchenne event
CureDuchenne has a variety of fundraising events throughout the year. These events have helped us fund seven research projects that have gone to human clinical trials. Join us for Dealing for Duchenne - Cambrdige on October 20 in Cambridge, MA.
Help Tyler Armstrong Climb to CureDuchenne.
Tyler is not just trying to set a world record; his goal is to raise awareness and funds to cure Duchenne muscular dystrophy, the most common and lethal muscle disease found in children. Duchenne afflicts approximately 300,000 boys worldwide.
Get the information you need to provide better care for those with Duchenne. The CureDuchenne Cares mission is to increase the health and wellbeing of patients living with Duchenne through educating parents, caregivers, clinicians, and physical therapists on best practices for Duchenne management. This program also keeps families informed on the latest scientific develipments in Duchenne research, including status and participation in clinical trials.
Together, we can CureDuchenne
Duchenne muscular dystrophy is a devastating muscle disease in children, affecting one in every 3,500 male births. Historically, Duchenne boys have not lived beyond their mid-20s. Those that do are faced with progressively weaker muscles and pulmonary and cardiac failure. The potential now exists, however, to make a difference in their quality of life.
Duplication Mutation Therapy for Duchenne
CureDuchenne has provided the lead funding for Dr. Flanigan's duplication research and is committed to helping bring this therapy into trials. We need your support in raising $710,000 to continue this important research.
Help Advance Research to Treat Heart Disease
CureDuchenne Ventures LLC is investing $1 million in Capricor Therapeutics to advance promising research to treat disease associated with Duchenne muscular dystrophy.
Moving research into practice
CureDuchenne’s accelerated push to move research from the lab into clinical trials could halt the progression of the disease and save the lives of thousands of Duchenne boys.
What is CureDuchenne?
CureDuchenne is a national nonprofit that raises awareness and funds to find a cure for Duchenne muscular dystrophy. The funds we raise support the most promising research programs aimed at treating and curing the disease. For the first time ever there is hope to find a cure for this destructive disease affecting thousands of boys and their families.
Sign up for our newsletter
Exon skipping drugs will be used to transform Duchenne muscular dystrophy into a much milder disease as seen in Becker muscular dystrophy patients. eDystrophin is an online database that provides information about inframe mutations typically seen in patients with milder forms of the disease. The database has been constructed using patient records and is easy to use and searchable by mutation type or clinical phenotype.
This informational webinar will highlight the regulatory process to date, update the community on Marathon Pharmaceutical’s Expanded Access Program (EAP) for deflazacort and discuss what a potential FDA approval of deflazacort would mean in terms of access to the drug in the United States. Some of those who currently import versions of deflazacort from abroad may have recently received an update from their distributor with initial details, which we will discuss along with steps current deflazacort patients might choose to take to help ensure continued access to U.S. supply of deflazacort if FDA approval is granted.Register Now!
The Latest from the Founder
A physical therapist is required to take on multiple roles while caring for their patients, and this is especially true when treating a complex condition such as Duchenne muscular dystrophy. It is these multiple roles and complicated diseases that keep Jerry Hsu, an Orange County, California-based physical therapist, excited about his job every day. Read more »Continue reading